BL, Ansari MQ, Chakrabarti BK, Roy MK, Ghosh AN, et al
. New phage typing scheme for Vibrio cholerae
O1 biotype El Tor strains. J Clin Microbiol 1993;31:1579-85.
Chakrabarti AK, Ghosh AN, Nair GB, Niyogi SK, Bhattacharya SK, Sarkar BL. Development and evaluation of a phage typing scheme for Vibrio cholerae
O139. J Clin Microbiol 2000;38:44-9.
Sarkar BL, Bhowmick TS, Das M, Rajendran K, Nair GB. Phage types of Vibrio cholerae
O1 and O139 in the past decade in India. Jpn J Infect Dis 2011;64:312-5.
Yen M, Cairns LS, Camilli A. A cocktail of three virulent bacteriophages prevents Vibrio cholerae
infection in animal models. Nat Commun 2017;8:14187.
Bhandare S, Colom J, Baig A, Ritchie JM, Bukhari H, Shah MA, et al
. Reviving phage therapy for the treatment of cholera. J Infect Dis 2019;219:786-94.
Sarkar A, Morita D, Ghosh A, Chowdhury G, Mukhopadhyay AK, Okamoto K, et al
. Altered integrative and conjugative elements (ICEs) in recent Vibrio cholera
O1 isolated from cholera cases, Kolkata, India. Front Microbiol 2019;10:2072.
Gupta PK, Pant ND, Bhandari R, Shrestha P. Cholera outbreak caused by drug resistant Vibrio cholerae
serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study. Antimicrob Resist Infect Control 2016;5:23.
Rijal N, Acharya J, Adhikari S, Upadhaya BP, Shakya G, Kansakar P, et al
. Changing epidemiology and antimicrobial resistance in Vibrio cholerae
: AMR surveillance findings (2006-2016) from Nepal. BMC Infect Dis 2019;19:801.
Uppal B, Mehra B, Panda PS, Kumar SK. Changing epidemiology and antimicrobial resistance pattern of Vibrio cholerae
isolates at a tertiary care health laboratory in North India (2011-2015). Trop J Med Res 2017;20:132-8. [Full text]
Sharma NC, Mandal PK, Dhillon R, Jain M. Changing profile of Vibrio cholerae
O1, O139 in Delhi and its periphery (2003-2005). Indian J Med Res 2007;125:633-40.
] [Full text]
Rashed SM, Hasan NA, Alam M, Sadique A, Sultana M, Hoq MM, et al
. Vibrio cholera
O1 with reduced susceptibility to ciprofloxacin and azithromycin isolated from a rural coastal area of Bangladesh. Front Microbiol 2017;8:252.
Das B, Verma J, Kumar P, Ghosh A, Ramamurthy T. Antibiotic resistance in Vibrio cholerae
: Understanding the ecology of resistance genes and mechanisms. Vaccine 2019. pii: S0264-410X(19)30793-5.
Huq A, Haley BJ, Taviani E, Chen A, Hasan NA, Colwell RR. Detection, isolation, and identification of Vibrio cholerae
from the environment. Curr Protoc Microbiol 2012; Chapter 6, Unit6A.5. Sep 2006.
Ansari MQ, Pal SC. Phage typing of Vibrio cholerae
01 biotype ElT or strains. Indian J Med Res 1990;91:263-5.
Alam MT, Ray SS, Chun CN, Chowdhury ZG, Rashid MH, Madsen Beau De Rochars VE, et al
. Major shift of toxigenic V. cholerae
O1 from Ogawa to Inaba serotype isolated from clinical and environmental samples in Haiti. PLoS Negl Trop Dis 2016;10:e0005045.
Stroeher UH, Karageorgos LE, Morona R, Manning PA. Serotype conversion in Vibrio cholerae
O1. Proc Natl Acad Sci U S A 1992;89:2566-70.
Khan AI, Chowdhury F, Harris JB, Larocque RC, Faruque AS, Ryan ET, et al
. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae
O1. Scand J Infect Dis 2010;42:48-56.
Jensen MA, Faruque SM, Mekalanos JJ, Levin BR. Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci U S A 2006;103:4652-7.
Nelson EJ, Chowdhury A, Harris JB, Begum YA, Chowdhury F, Khan AI, et al
. Complexity of rice-water stool from patients with Vibrio cholerae
plays a role in the transmission of infectious diarrhea. Proc Natl Acad Sci U S A 2007;104:19091-6.
Furfaro LL, Payne MS, Chang BJ. Bacteriophage therapy: Clinical trials and regulatory hurdles. Front Cell Infect Microbiol 2018;8:376.
Vahedi A, Soltan Dallal MM, Douraghi M, Nikkhahi F, Rajabi Z, Yousefi M, et al
. Isolation and identification of specific bacteriophage against enteropathogenic Escherichia coli
(EPEC) andin vitro
characterization of bacteriophage. FEMS Microbiol Lett 2018;365. pii: fny136.
Chadha